{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:27:31Z","timestamp":1791829651467,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spleen stiffness measurement (SSM) performed by transient elastography at 100\u00a0Hz is a novel technology for the evaluation of portal hypertension in advanced chronic liver disease, but technical aspects are lacking. We aimed to evaluate the intraexamination variability of SSM and to determine the best transient elastography protocol for obtaining robust measurements to be used in clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed 253 SSM exams with up to 20 scans for each examination, performed between April 2021 and June 2022. All SSM results were evaluated according to different protocols by dividing data into groups of <jats:italic>n<\/jats:italic> measurements (from 2 to 19). Considering as reference the median SSM values across all the 20 measurements, we calculated the distribution of the absolute deviations of each protocol from the reference median. This analysis was repeated 1,000 times by resampling the data. Distributions were also stratified by etiology (chronic liver disease <jats:italic>versus<\/jats:italic> clinically significant portal hypertension) and different SSM ranges:\u2009&lt;\u200925\u00a0kPa, 25\u201375, and\u2009&gt;\u200975\u00a0kPa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, we observed that the spleen stiffness exam had less variability if it exceeded 12 measurements, <jats:italic>i.e.<\/jats:italic>, absolute deviations\u2009\u2264\u20095\u00a0kPa at 95% confidence. For exams with higher SSM values (&gt;\u200975\u00a0kPa), as seen in clinically significant portal hypertension, at least 15 measurements are highly recommendable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Fifteen scans per examination should be considered for each SSM exam performed at 100\u00a0Hz to achieve a low intraexamination variability within a reasonable time in clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Relevance statement<\/jats:title>\n                <jats:p>Performing at least 15 scans per examination is recommended for 100\u00a0Hz SSM in order to achieve a low intraexamination variability, in particular for values\u2009&gt;\u200975\u00a0kPa compatible with clinically significant portal hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key points<\/jats:title>\n                <jats:p>\u2022 Spleen stiffness measurement by transient elastography is used for stratification in patients with portal hypertension.<\/jats:p>\n                <jats:p>\u2022 At 100\u00a0Hz, this method may have intraexamination variability.<\/jats:p>\n                <jats:p>\u2022 A minimum of 15 scans per examination achieves a low intraexamination variability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s41747-023-00393-2","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T17:02:22Z","timestamp":1702400542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Variability of transient elastography-based spleen stiffness performed at 100\u00a0Hz"],"prefix":"10.1186","volume":"7","author":[{"given":"Angelo","family":"Armandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Merizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle Marie","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey O.","family":"Coxson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Sanavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Birolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Gashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Ertle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Galle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-4703","authenticated-orcid":false,"given":"J\u00f6rn M.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"393_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D\u2019Amico","year":"2018","unstructured":"D\u2019Amico G, Morabito A, D\u2019Amico M et al (2018) Clinical states of cirrhosis and competing risks. J Hepatol 68:563\u2013576. https:\/\/doi.org\/10.1016\/j.jhep.2017.10.020","journal-title":"J Hepatol"},{"key":"393_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/lt.25443","volume":"25","author":"P Axley","year":"2019","unstructured":"Axley P, Ahmed Z, Arora S et al (2019) NASH is the most rapidly growing etiology for acute-on-chronic liver failure-related hospitalization and disease burden in the United States: a population-based study. Liver Transpl 25:695\u2013705. https:\/\/doi.org\/10.1002\/lt.25443","journal-title":"Liver Transpl"},{"key":"393_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/liv.14825","volume":"41","author":"JM Schattenberg","year":"2021","unstructured":"Schattenberg JM, Lazarus JV, Newsome PN et al (2021) Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: a cost-of-illness analysis. Liver Int 41:1227\u20131242. https:\/\/doi.org\/10.1111\/liv.14825","journal-title":"Liver Int"},{"key":"393_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/liv.15013","volume":"41","author":"J Rivera-Esteban","year":"2021","unstructured":"Rivera-Esteban J, Armandi A, Augustin S, Bugianesi E (2021) Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis. Liver Int 41:1999\u20132008. https:\/\/doi.org\/10.1111\/liv.15013","journal-title":"Liver Int"},{"key":"393_CR5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1572-0241.2004.30754.x","volume":"99","author":"LE Targownik","year":"2004","unstructured":"Targownik LE, Spiegel BM, Dulai GS, Karsan HA, Gralnek IM (2004) The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am J Gastroenterol 99:1306\u20131315. https:\/\/doi.org\/10.1111\/j.1572-0241.2004.30754.x","journal-title":"Am J Gastroenterol"},{"key":"393_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jhep.2013.08.013","volume":"60","author":"R Khanna","year":"2014","unstructured":"Khanna R, Sarin SK (2014) Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol 60:421\u2013441. https:\/\/doi.org\/10.1016\/j.jhep.2013.08.013","journal-title":"J Hepatol"},{"key":"393_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA et al (2022) Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut 71:1006\u20131019. https:\/\/doi.org\/10.1136\/gutjnl-2021-324243","journal-title":"Gut"},{"key":"393_CR8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Faculty BVII (2022) Baveno VII - renewing consensus in portal hypertension. J Hepatol 76:959\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022","journal-title":"J Hepatol"},{"key":"393_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jhep.2018.04.023","volume":"69","author":"A Colecchia","year":"2018","unstructured":"Colecchia A, Ravaioli F, Marasco G et al (2018) A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol 69:308\u2013317. https:\/\/doi.org\/10.1016\/j.jhep.2018.04.023","journal-title":"J Hepatol"},{"key":"393_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/a-1205-0367","volume":"43","author":"E Dajti","year":"2022","unstructured":"Dajti E, Ravaioli F, Colecchia A et al (2022) Spleen stiffness measurements predict the risk of hepatic decompensation after direct-acting antivirals in HCV cirrhotic patients. Ultraschall Med 43:280\u2013288. https:\/\/doi.org\/10.1055\/a-1205-0367","journal-title":"Ultraschall Med"},{"key":"393_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s12072-020-10062-w","volume":"14","author":"G Marasco","year":"2020","unstructured":"Marasco G, Dajti E, Ravaioli F et al (2020) Spleen stiffness measurement for assessing the response to \u03b2-blockers therapy for high-risk esophageal varices patients. Hepatol Int 14:850\u2013857. https:\/\/doi.org\/10.1007\/s12072-020-10062-w","journal-title":"Hepatol Int"},{"key":"393_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/liv.13560","volume":"38","author":"GLH Wong","year":"2018","unstructured":"Wong GLH, Kwok R, Hui AJ et al (2018) A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: a randomized trial. Liver Int 38:636\u2013644. https:\/\/doi.org\/10.1111\/liv.13560","journal-title":"Liver Int"},{"key":"393_CR13","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.ultrasmedbio.2018.03.028","volume":"44","author":"C Bastard","year":"2018","unstructured":"Bastard C, Miette V, Cal\u00e8s P, Stefanescu H, Festi D, Sandrin L (2018) A novel FibroScan examination dedicated to spleen stiffness measurement. Ultrasound Med Biol 44:1616\u20131626. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2018.03.028","journal-title":"Ultrasound Med Biol"},{"key":"393_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/liv.14228","volume":"40","author":"H Stefanescu","year":"2020","unstructured":"Stefanescu H, Marasco G, Cal\u00e8s P et al (2020) A novel spleen-dedicated stiffness measurement by FibroScan\u00ae improves the screening of high-risk oesophageal varices. Liver Int 40:175\u2013185. https:\/\/doi.org\/10.1111\/liv.14228","journal-title":"Liver Int"},{"key":"393_CR15","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s10620-015-3611-2","volume":"60","author":"E Ju\u00e1rez-Hern\u00e1ndez","year":"2015","unstructured":"Ju\u00e1rez-Hern\u00e1ndez E, Uribe-Ramos MH, Ramos-Ostos MH et al (2015) Factors associated with the quality of transient elastography. Dig Dis Sci 60:2177\u20132182. https:\/\/doi.org\/10.1007\/s10620-015-3611-2","journal-title":"Dig Dis Sci"},{"key":"393_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/1751-2980.12359","volume":"17","author":"GL Wong","year":"2016","unstructured":"Wong GL, Kwok R, Chan H et al (2016) Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers. J Dig Dis 17:538\u2013546. https:\/\/doi.org\/10.1111\/1751-2980.12359","journal-title":"J Dig Dis"},{"key":"393_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/MEG.0b013e328346c0f7","volume":"23","author":"S Zelber-Sagi","year":"2011","unstructured":"Zelber-Sagi S, Yeshua H, Shlomai A et al (2011) Sampling variability of transient elastography according to probe location. Eur J Gastroenterol Hepatol 23:507\u2013514. https:\/\/doi.org\/10.1097\/MEG.0b013e328346c0f7","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"393_CR18","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/liv.12551","volume":"35","author":"H Perazzo","year":"2015","unstructured":"Perazzo H, Fernandes FF, Gomes A, Terra C, Perez RM, Figueiredo FA (2015) Interobserver variability in transient elastography analysis of patients with chronic hepatitis C. Liver Int 35:1533\u20131539. https:\/\/doi.org\/10.1111\/liv.12551","journal-title":"Liver Int"},{"key":"393_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1365-2893.2012.01608.x","volume":"19","author":"B Roca","year":"2012","unstructured":"Roca B, Resino E, Torres V, Herrero E, Penades M (2012) Interobserver discrepancy in liver fibrosis using transient elastography. J Viral Hepat 19:711\u2013715. https:\/\/doi.org\/10.1111\/j.1365-2893.2012.01608.x","journal-title":"J Viral Hepat"},{"key":"393_CR20","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.7863\/ultra.15.10056","volume":"35","author":"M Balakrishnan","year":"2016","unstructured":"Balakrishnan M, Souza F, Mu\u00f1oz C et al (2016) Liver and spleen stiffness measurements by point shear wave elastography via acoustic radiation force impulse: intraobserver and interobserver variability and predictors of variability in a US population. J Ultrasound Med 35:2373\u20132380. https:\/\/doi.org\/10.7863\/ultra.15.10056","journal-title":"J Ultrasound Med"},{"key":"393_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/jvh.12119","volume":"21","author":"M Fraquelli","year":"2014","unstructured":"Fraquelli M, Giunta M, Pozzi R et al (2014) Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis. J Viral Hepat 21:90\u201398. https:\/\/doi.org\/10.1111\/jvh.12119","journal-title":"J Viral Hepat"},{"key":"393_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jvh.12296","volume":"22","author":"JA Carri\u00f3n","year":"2015","unstructured":"Carri\u00f3n JA, Puigveh\u00ed M, Coll S et al (2015) Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators. J Viral Hepat 22:297\u2013306. https:\/\/doi.org\/10.1111\/jvh.12296","journal-title":"J Viral Hepat"},{"key":"393_CR23","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/jgh.13762","volume":"32","author":"M Puigveh\u00ed","year":"2017","unstructured":"Puigveh\u00ed M, Broquetas T, Coll S et al (2017) Impact of anthropometric features on the applicability and accuracy of FibroScan\u00ae (M and XL) in overweight\/obese patients. J Gastroenterol Hepatol 32:1746\u20131753. https:\/\/doi.org\/10.1111\/jgh.13762","journal-title":"J Gastroenterol Hepatol"},{"key":"393_CR24","unstructured":"ClinicalTrials.gov NCT05122416: optimization of spleen VCTE examinations with FibroScan.\u00a0Available via https:\/\/clinicaltrials.gov\/study\/NCT05044663"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00393-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-023-00393-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00393-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T17:08:55Z","timestamp":1702400935000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-023-00393-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1186\/s41747-023-00393-2","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained, and the study protocol was approved by the ethics committee of the Landes\u00e4rztekammer Rheinland-Pfalz Nr. 873.199.10 (7208). The study was conducted according to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008). All patients gave informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JMS: consultant\u2014Astra Zeneca, Apollo Endosurgery, Bayer, Boehringer Ingelheim, BMS, Gilead Sciences, GSK, Intercept Pharmaceuticals, Ipsen, Inventiva Pharma, Madrigal, MSD, Northsea Therapeutics, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and Siemens Healthineers; research funding\u2014Gilead Sciences, Boehringer Ingelheim, and Siemens Healthcare GmbH; stock options\u2014AGED diagnostics and Hepta Bio; speaker honorarium\u2014Boehringer Ingelheim, Echosens, MedPublico GmbH, Novo Nordisk, Madrigal Pharmaceuticals, Histoindex, and MedPublico GmbH.HC, IG, and JE are employees of Boehringer Ingelheim.TE is a member of the <i>European Radiology Experimental<\/i> Scientific Editorial Board. He has not taken part in the review or selection process of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}